Allergy Therapeutics plc (AIM:AGY)
London flag London · Delayed Price · Currency is GBP · Price in GBX
5.40
-0.58 (-9.70%)
Jul 27, 2026, 4:35 PM GMT

Allergy Therapeutics Financials Overview

Millions GBP. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
57.2955.0455.259.5972.7784.33
Revenue Growth
4.09%-0.28%-7.36%-18.11%-13.71%7.83%
Gross Profit
29.9229.329.7433.2549.5162.23
Operating Income
-30.93-28.16-35.26-39.65-12.254.03
Net Income
-48.97-40.13-38.62-43.07-13.782.89
Earnings Per Share
-0.01-0.01-0.01-0.06-0.020.00
EPS Growth
------59.05%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '24 Jun '23 Jun '22 Jun '21
Germany
26.6927.331.7642.5853.8
Austria
5.264.954.95.235.6
Netherlands
3.964.064.024.284.17
Switzerland
2.342.862.843.33.14
Italy
2.873.073.053.43.97
Spain
9.68.889.388.878.42
Other Southern Europe
0.20.370.40.560.53
Inter Segment
-30.63-30.41-28.73-39.37-53.98
Rest of World (Including UK)
34.7834.1231.9843.9258.68
Total
55.0455.259.5972.7784.33

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
10.0812.7912.9214.8520.5240.27
Total Debt
26.7560.0930.9935.9910.5311.17
Net Cash (Debt)
-16.67-47.3-18.07-21.149.9929.1
Net Cash Growth
-----65.69%17.42%
Net Cash Per Share
-0.00-0.01-0.00-0.030.020.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-32.16-28.11-32.14-28.88-148.59
Capital Expenditures
-4.55-3.26-3.4-4.67-3.06-2.56
Free Cash Flow
-36.71-31.37-35.54-33.55-17.066.03
Free Cash Flow Growth
------41.03%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
52.22%53.23%53.87%55.79%68.03%73.79%
Operating Margin
-53.98%-51.16%-63.87%-66.55%-16.83%4.78%
Pretax Margin
-82.33%-71.22%-70.95%-70.09%-17.39%4.34%
Profit Margin
-85.46%-72.91%-69.97%-72.28%-18.93%3.42%
FCF Margin
-64.07%-57.00%-64.38%-56.30%-23.44%7.15%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
-----58.14
Forward PE
-63.3163.3163.3163.3163.31
P/FCF Ratio
-----26.62
PS Ratio
5.976.884.520.121.841.90